JP2007537212A5 - - Google Patents

Download PDF

Info

Publication number
JP2007537212A5
JP2007537212A5 JP2007512277A JP2007512277A JP2007537212A5 JP 2007537212 A5 JP2007537212 A5 JP 2007537212A5 JP 2007512277 A JP2007512277 A JP 2007512277A JP 2007512277 A JP2007512277 A JP 2007512277A JP 2007537212 A5 JP2007537212 A5 JP 2007537212A5
Authority
JP
Japan
Prior art keywords
group
alkyl
formula
aryl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007512277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007537212A (ja
JP4909889B2 (ja
Filing date
Publication date
Priority claimed from FR0405055A external-priority patent/FR2870239B1/fr
Application filed filed Critical
Publication of JP2007537212A publication Critical patent/JP2007537212A/ja
Publication of JP2007537212A5 publication Critical patent/JP2007537212A5/ja
Application granted granted Critical
Publication of JP4909889B2 publication Critical patent/JP4909889B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007512277A 2004-05-11 2005-05-10 2h−又は3h−ベンゾ[e]インダゾール1−イルカルバメート誘導体、これらの調製及び治療的使用 Expired - Fee Related JP4909889B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0405055 2004-05-11
FR0405055A FR2870239B1 (fr) 2004-05-11 2004-05-11 Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
PCT/FR2005/001154 WO2005121099A1 (fr) 2004-05-11 2005-05-10 Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
JP2007537212A JP2007537212A (ja) 2007-12-20
JP2007537212A5 true JP2007537212A5 (enExample) 2012-02-02
JP4909889B2 JP4909889B2 (ja) 2012-04-04

Family

ID=34947852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007512277A Expired - Fee Related JP4909889B2 (ja) 2004-05-11 2005-05-10 2h−又は3h−ベンゾ[e]インダゾール1−イルカルバメート誘導体、これらの調製及び治療的使用

Country Status (32)

Country Link
US (3) US7501449B2 (enExample)
EP (1) EP1747201B8 (enExample)
JP (1) JP4909889B2 (enExample)
KR (1) KR101165483B1 (enExample)
CN (1) CN100577648C (enExample)
AR (1) AR049090A1 (enExample)
AT (1) ATE411295T1 (enExample)
AU (1) AU2005251982B2 (enExample)
BR (1) BRPI0508563A (enExample)
CA (1) CA2557942C (enExample)
CR (1) CR8570A (enExample)
CY (1) CY1108710T1 (enExample)
DE (1) DE602005010418D1 (enExample)
DK (1) DK1747201T3 (enExample)
EC (1) ECSP066810A (enExample)
ES (1) ES2315898T3 (enExample)
FR (1) FR2870239B1 (enExample)
HR (1) HRP20090012T3 (enExample)
IL (1) IL177632A (enExample)
MA (1) MA28372A1 (enExample)
NO (1) NO20064073L (enExample)
NZ (1) NZ549330A (enExample)
PL (1) PL1747201T3 (enExample)
PT (1) PT1747201E (enExample)
RS (1) RS50724B (enExample)
RU (1) RU2379293C2 (enExample)
SI (1) SI1747201T1 (enExample)
TN (1) TNSN06258A1 (enExample)
TW (1) TWI349004B (enExample)
UA (1) UA85866C2 (enExample)
WO (1) WO2005121099A1 (enExample)
ZA (1) ZA200607244B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2870239B1 (fr) 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
WO2007088528A1 (en) * 2006-02-03 2007-08-09 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Microtubule targeting agents
CL2008000793A1 (es) * 2007-03-23 2008-05-30 Xenon Pharmaceuticals Inc Compuestos derivados de dihidroindazol; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno del hierro.
PL3022185T3 (pl) * 2013-07-15 2018-02-28 Basf Se Związki szkodnikobójcze

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0607076A1 (fr) * 1993-01-15 1994-07-20 Synthelabo Dérivés de 9h-imidazo 1,2-a benzimidazole-3-acétamide à activité GABA
TW403738B (en) * 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives
FR2741073B1 (fr) * 1995-11-09 1997-12-12 Synthelabo Derives de 4,5-dihydroimidazo(1,2-a)pyrrolo(1,2,3-cd) benzimidazole, leur preparation et leur application en therapeutique
AR006520A1 (es) * 1996-03-20 1999-09-08 Astra Pharma Prod Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.
ZA9810490B (en) * 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
BR0113697A (pt) * 2000-09-06 2003-07-22 Neurogen Corp Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou sal, embalagem e métodos para, para alterar a atividade transdutora de sinal dos receptores de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, para demonstrar a presença dos receptores de gabaa em células ou amostras de tecido e para preparar um composto
AU9022901A (en) * 2000-09-18 2002-03-26 Eisai Co Ltd Pyridazinones and triazinones and medicinal use thereof
FR2870239B1 (fr) * 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.

Similar Documents

Publication Publication Date Title
JP2018536634A5 (enExample)
JP2011037841A5 (enExample)
WO2009112678A3 (fr) Derives de carboxam i d es azabicycliques, leur preparation et leur application en therapeutique.
JP2014503574A5 (enExample)
JP2019524883A5 (enExample)
WO2009112677A3 (fr) Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique.
JP2010506942A5 (enExample)
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
JP2007508359A5 (enExample)
JP2015143283A5 (enExample)
JP2007524696A5 (enExample)
JP2011519854A5 (enExample)
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
EA026437B1 (ru) N-(3-((4-ацилпиперазин-1-ил)метил)фенил)амиды в качестве модуляторов сиротских гамма-рецепторов ретиноидов (ror-гамма) и их применение для лечения рассеянного склероза и псориаза
JP2014510774A5 (enExample)
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
JP2018531987A5 (enExample)
WO2010033643A3 (en) Small molecule compounds for stem cell differentiation
JP2007246474A5 (enExample)
JP2016540803A5 (enExample)
JP2015508092A5 (enExample)
JP2018529690A5 (enExample)
JP2019527724A5 (enExample)
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2010506919A5 (enExample)